Art. 57 Directive (EU) 2001/83

In forcesince 21 Jul 2011cited 4×

Notwithstanding Article 60, Member States may require the use of certain forms of labelling of the medicinal product making it possible to ascertain:

the price of the medicinal product,

the reimbursement conditions of social security organizations,

the legal status for supply to the patient, in accordance with Title VI,

authenticity and identification in accordance with Article 54a(5).

For medicinal products authorised under Regulation (EC) No 726/2004, Member States shall, when applying this Article, observe the detailed guidance referred to in Article 65 of this Directive.

  • Directive (EU) 2011/62Lawamends

  • Directive (EU) 2004/27Lawamends

  • Judgment of the Court (Fifth Chamber) of 17 November 2022. Merck Sharp & Dohme BV and Others v Abacus Medicine A/S and Others.Decision

    Article 57 of that directive provides: ‘Notwithstanding Article 60, Member States may require the use of certain forms of labelling of the medicinal product making it possible to ascertain: the price of the medicinal product, the …

    17 Nov 2022 · 62020CJ0224

  • Conseil d'État, 1ère - 4ème chambres réunies, 08/04/2024, 470279Decision

    8 Apr 2024 · CETATEXT000049404930